Showing 8441-8450 of 19301 results for "".
- COVID-19 and Pediatric Type 1 Diabetes: Incidence, Presentation, and Managementhttps://reachmd.com/news/covid-19-and-pediatric-type-1-diabetes-incidence-presentation-and-management/2474240/The COVID-19 pandemic didn’t just stretch global healthcare systems to their limits—it quietly reshaped the clinical trajectory of chronic diseases, including pediatric type 1 diabetes. Around the world, clinicians began noticing something troubling: a marked incre
- Earlier Onset of Type 2 Diabetes Tied to Increased Dementia Riskhttps://reachmd.com/news/earlier-onset-of-type-2-diabetes-tied-to-increased-dementia-risk/2468695/A new study from the NYU Rory Meyers College of Nursing reveals that adults diagnosed with type 2 diabetes at a younger age face a higher risk of developing dementia later in life. Published in PLOS ONE, the research highlights how this risk is further compounded for individuals with obe
- Inconsistent Sleep Patterns Linked to Increased Type 2 Diabetes Risk: Studyhttps://reachmd.com/news/inconsistent-sleep-patterns-linked-to-increased-type-2-diabetes-risk-study/2467493/Regular sleep could play a crucial role in preventing type 2 diabetes, according to a recent study conducted by researchers at Brigham and Women’s Hospital. The study highlighted that individuals with irregular sleep patterns have a significantly higher risk of de
- Navigating Emerging Therapies in CKD Management for Type 2 Diabeteshttps://reachmd.com/news/navigating-emerging-therapies-in-ckd-management-for-type-2-diabetes/2475921/Nephrologists are now navigating a pivotal moment in treating chronic kidney disease in type 2 diabetes, where emerging therapies promise to alter both renal and cardiovascular trajectories. Managing CKD in the context of type 2 diabetes has long required balancing glycemic control w
- Exosomal miRNAs in Type 2 Diabetes Remission: Untangling Molecular Predictorshttps://reachmd.com/news/exosomal-mirnas-in-type-2-diabetes-remission-untangling-molecular-predictors/2475899/Clinicians increasingly confront a paradox: while low-calorie dietary interventions can trigger remission in type 2 diabetes, the molecular predictors of who will respond remain obscure. According to the American Diabetes Association, remission is defined as achieving an HbA1c level below 6
- Clinical Evaluation in Type 1 Diabetes: Body Composition and Activity Patternshttps://reachmd.com/news/clinical-evaluation-in-type-1-diabetes-body-composition-and-activity-patterns/2474111/Recent controlled studies have identified several significant differences between patients with Type 1 Diabetes and their non-diabetic counterparts. A key finding is that many T1DM patients present with an elevated body mass index (BMI) and higher body fat percenta
- Leveraging Community Leaders and Churches to Tackle Type 2 Diabetes in Rural Areashttps://reachmd.com/news/leveraging-community-leaders-and-churches-to-tackle-type-2-diabetes-in-rural-areas/2468765/Rural communities face unique challenges in accessing healthcare and prevention resources, contributing to rising rates of Type 2 diabetes. A recent study from the University of Georgia highlights a promising solution: involving local leaders and churches in delivering diabetes prevention program
- Genetics Predict Type 2 Diabetes Risk and Disparities in Childhood Cancer Survivorshttps://reachmd.com/news/genetics-predict-type-2-diabetes-risk-and-disparities-in-childhood-cancer-survivors/2462854/Genetics amplify diabetes risk from alkylating agents in survivors The research also suggested that another contributor to increased type 2 diabetes risk is exposure to alkylating agents, a class of chemotherapy commonly used in childhood cancer treatments. “We s
- AVAnT1A Study: Investigating Early COVID-19 Vaccination and Type 1 Diabetes Risk in Childrenhttps://reachmd.com/news/avant1a-study-investigating-early-covid-19-vaccination-and-type-1-diabetes-risk-in-children/2462996/Type 1 diabetes is an autoimmune disease that leads to disrupted glucose metabolism. It requires lifelong insulin therapy. The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) collaborates within a European network to develop new
- Telemedicine for Type 2 Diabetes: Meta-analysis Shows HbA1c and Cardiometabolic Benefitshttps://reachmd.com/news/telemedicine-for-type-2-diabetes-meta-analysis-shows-hba1c-and-cardiometabolic-benefits/2485748/A systematic review and meta-analysis of randomized trials in adults with type 2 diabetes compared telemedicine interventions with usual care and reported a pooled reduction in HbA1c favoring tel